Delivery Order SPE2DB22D3501-SPE2DB25FVW41
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,584.30 to AmerisourceBergen Drug Corp for Isotretinoin 20 mg capsules (30-count packaging) on September 8, 2025, with an ultimate completion date of September 9, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is performed at the contractor's Conshohocken, Pennsylvania location. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $3,976.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 9, 2025, for the supply of Isotretinoin 30 mg capsules (30-count units). This is a non-set-aside contract with a performance location in Conshohocken, Pennsylvania, and an ultimate completion date of June 10, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Isotretinoin 30 mg capsules (30-count) with a contract ceiling value of $1,645.60. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, was competitively awarded with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Isotretinoin 20 mg capsules (30-count units) with a ceiling value of $1,225.40. This is a firm fixed-price delivery order with no set-aside designation, awarded on September 5, 2025, with an ultimate completion date of September 8, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,085.34 by the Defense Logistics Agency (DLA) on August 26, 2025, for the supply of Isotretinoin 30 mg capsules (30-count packaging). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 27, 2025. The contract will be performed at the awardee's Conshohocken,...
- The Defense Logistics Agency awarded a $7,847.37 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Isotretinoin 30 mg capsules (30-count units). This is a firm fixed price, non-set-aside contract with a completion date of September 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count) under a firm fixed-price contract valued at $6,065.50. The order was competitively awarded without a set-aside designation and carries an ultimate completion date of September 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $4,958.75 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count packaging) on September 9, 2025, with an ultimate completion date of September 10, 2025. This firm fixed-price, non-set-aside contract was awarded competitively and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 vehicle running...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,984.14 to supply Isotretinoin 30 mg capsules (30-count units) with a completion date of June 20, 2025. This firm fixed-price delivery order was awarded competitively without set-aside designation on June 18, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $6,969.33 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count packaging) with a firm fixed price contract type. The contract was competitively awarded without a set-aside designation and is scheduled for completion by April 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and deliver this pharmaceutical product to...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FVW41Delivery Order
The Defense Logistics Agency (DLA) awarded a $1,567.08 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Isotretinoin 40 mg capsules (30-count). This is a firm fixed price, competitively awarded contract with no set-aside designation, scheduled for completion by June 2, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters and primary distribution operations. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor agreement running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has established itself as a critical federal vendor for medical procurement through its extensive contract portfolio with the DLA and Defense Health Agency. The company's demonstrated capability to deliver across a broad spectrum of pharmaceutical products—from specialty medications and brand-name drugs to generics and vaccines—makes it well-positioned to support military and veteran healthcare systems. This award reflects AmerisourceBergen's continued role as a primary pharmaceutical supplier within the federal medical supply chain, serving multiple government healthcare customers through competitive, firm fixed-price delivery mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 5/30/25 |